Items where Author is "Quayle, Lewis"

MORITA, Mai, ARSHAD, Fawaz, QUAYLE, Lewis, GEORGE, Christopher N, LEFLEY, Diane V., KALAJZIC, Ivo, BALSUBRAMANIAN, Meena, CEBE, Tugba, REILLY, Gwen, BISHOP, Nicolas J. and OTTEWELL, Penelope D. (2024). Losartan alters osteoblast differentiation and increases bone mass through inhibition of TGFB signalling in vitro and in an OIM mouse model. Bone Reports: 101795.

GRIFFIN, Jon, DOWN, Jenny, QUAYLE, Lewis, HEATH, Paul R, GIBB, Ewan A, DAVICIONI, Elai, LIU, Yang, ZHAO, Xin, SWAIN, Jayne, WANG, Dennis, HUSSAIN, Syed, CRABB, Simon and CATTO, James WF (2024). Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial. The Journal of Pathology: Clinical Research, 10 (2): e12363.

CRABB, Simon, HUSSAIN, Syed, OUGHTON, Jamie, SWAIN, Jayne, CAIRNS, David, COLLINSON, Michelle, AINSWORTH, Gemma, MCCREADY, Dominic, GRIFFIN, Jon, HEATH, Paul, QUAYLE, Lewis, DOWN, Jenny, WANG, Dennis, KNIGHT, Allen, GIBB, Ewan, DAVICIONI, Elai, LIU, Yang and CATTO, James (2024). Use of gene expression patterns to identify unique molecular subtypes in muscle invasive bladder cancer: GUSTO [abstract only]. Journal of Clinical Oncology, 42 (16 sup).

GRIFFIN, Jonathan, DOWN, Jenny, QUAYLE, Lewis, HEATH, Paul and CATTO, James (2023). Pathology against the clock: Verification of gene expression subtyping for the GUSTO clinical trial [abstract only]. The Journal of Pathology, 261 (S1): P85.

QUAYLE, Lewis (2022). quicKM: an online tool for speedy survival analysis. Sheffield University.

QUAYLE, Lewis, OTTEWELL, Penelope and HOLEN, Ingunn (2018). Therapeutic Resistance and Stemness in Mitotically Quiescent Human Breast Cancer Cells [Abstract only]. Breast Cancer Research and Treatment, 167, 309-405.

QUAYLE, Lewis, OTTEWELL, Penelope and HOLEN, Ingunn (2018). Therapeutic resistance and stemness in mitotically quiescent human breast cancer cells [abstract only]. Breast Cancer Research and Treatment, 167 (1), 393-394.

QUAYLE, Lewis, PARK, S., MCDONNELL, D.P., OTTEWELL, P.D. and HOLEN, I. (2017). Abstract P3-07-14: Targeting ERR-α regulated lactate metabolism eliminates drug-resistant breast cancer cells. Cancer Research, 77 (4_Supp).